Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics vs Bismuth Quadruple Therapy for H. pylori Eradication
NCT05237115Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of clostridium butyricum, bacillus coagulans in Helicobacter pylori infection, sponsored by Xijing Hospital of Digestive Diseases. Started May 2020; status: completed.
02
Drugs
clostridium butyricumbacillus coagulans
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05237115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237115.